Chemical and Biomolecular Engineering, Department of

 

Date of this Version

2011

Document Type

Article

Citation

Patent No.: US 7,867,974 B2

Comments

Appl. No.: 11/734,489

Abstract

Disclosed herein is a simple method for the treatment of antigen-deficiency diseases, by orally administering to a Subject a therapeutically effective amount of the deficient anti gen, wherein the antigen is not present in a liposome. In one embodiment, the method increases hemostasis in a subject having hemophilia A or B, by orally administering to the hemophiliac atherapeutically effective amount of the appropriate clotting factor other than in a liposome, Sufficient to induce oral tolerance and Supply exogenous clotting factor to the subject.

Share

COinS